United Kingdom · 
Who invested in Thalia Therapeutics?
Thalia Therapeutics's investors include Innovate UK.
United Kingdom · Funded startup
Who invested in Thalia Therapeutics
Funding summaryUpdated 26 Oct 2026
$3.6Mraised across 1 round since 2026, from 1 source
- Latest round
- Secondary, $3.6MJun 2026
- Investors
- 1
The rounds
- Jun 2026
Founders and team
From Thalia Therapeutics's own website: 11 on the team.
- Dr David H SolomonChief Executive Officer
- Luke CairnsChief Financial Officer
- Dr Fiona McLaughlinHead of Research and Development
- Dr Margaret CourtneyHead of Pharmaceutical Development
- Dr Mark EdbrookeHead of Strategy
- Dr Simon BennettHead of Business Development
- Dr Alastair SmithNon-Executive Director
- Dr Chris BrittenNon-Executive Chairman
- Dr Michael G. PalfreymanNon-Executive Director
- Dr Rachel SchillerDirector, Scientific Programme Management and Operations
- Edward WardleNon-Executive Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Thalia Therapeutics
How much has Thalia Therapeutics raised?
Thalia Therapeutics has raised $3.6M across 1 round since 2026.
When did Thalia Therapeutics last raise?
Thalia Therapeutics's most recent round was a Secondary of $3.6M in Jun 2026.
What was Thalia Therapeutics's biggest round?
Its most recent round, $3.6M in Jun 2026, is also its largest on record.
Who backed Thalia Therapeutics first?
Thalia Therapeutics's first round on record, in Jun 2026, was backed by Innovate UK.
What stage is Thalia Therapeutics at?
Thalia Therapeutics's latest named round is a Secondary, in Jun 2026.
Where is Thalia Therapeutics based?
Thalia Therapeutics is based in the United Kingdom.
Companies like Thalia Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.